http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101486713-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b1eac93fa8426bfd541c9e14e11860 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 |
| filingDate | 2009-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c465525b6ef3e067ed7af6cf053966a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36505b91b6fdcf7800a12e7544a9dc46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dd343cbbd58ca883f3bd1c77cfb47fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc8c9dc763a6393251453615e397639b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_180e08994e72c30c3e48b283d8db13b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c94013f963c8f9c5e1e2c5252172e4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_829cb9f2446d5ca0b2bb11f27acf672d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3195fca4f530ff8ecdcee58c7cc0d9b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543e41894830c9a101bf69aeef3c2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ea57f6d12c4410e5eb834bef460b266 |
| publicationDate | 2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101486713-A |
| titleOfInvention | Furo[2,3-h] chromene compound and use for preventing platelet aggregation |
| abstract | The invention pertains to the field of medical technology and relates to a furo [2, 3-h] chromene compound and an application thereof for inhibiting platelet aggregation; the furo [2, 3-h] chromene compound, pharmaceutically-acceptable salt, or stereo-isomers and pre-drugs of the furo [2, 3-h] chromene compound, as well as pharmaceutical compatibility acceptable carriers or diluents of the furo [2, 3-h] chromene compound can be used as platelet aggregation inhibitors. The structural formula of the furo [2, 3-h] chromene compound is as shown above, wherein, X can be chosen from CH2 or C=O, R1 can be independently chosen from H or a substituted or un-substituted aromatic base, R2 can be independently chosen from H or a substituted or un-substituted aromatic base, and R can be independently chosen from H, alkyl group with one to four carbon atoms, chlorine, bromine, fluorin, methoxyl, nitryl or hydroxyl. The furo [2, 3-h] chromene compound has simple synthetic method, adapts to industrialized production and is more stable compared with natural analogues. Shown by biological activity assay, the furo [2, 3-h] chromene compound has antithrombin activity and is a platelet aggregation inhibiting drug. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105153177-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877949-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011131026-A1 |
| priorityDate | 2009-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.